FAQs

Addressing key questions across compliance, execution, and MedTech growth

Top Customer Questions

Yes. Under the provision of Drugs and Cosmetic act 1940, CDSCO registration and import license is required to import Medical Devices in India. For the introduction of medical device in the Indian market, the Manufacturers has to obey various norms set by national regulatory bodies of India. The main regulatory body for medical device in India is Central Drugs Standard Control Organization (CDSCO). The Application for all classes of medical devices as per CDSCO guidelines are submitted to Central Licensing Authority, where the (DCGI) Drug Controller General of India takes the responsibility for approval of Manufacturing, Registration, Import and Sale of Medical Devices in India. When the Medical Device released to be imported it has some issued steps to be followed. Only those medical devices require import license which are listed in Notified medical devices by CDSCO.

To apply for a Medical Device Import License in India, you need to submit your application online through the CDSCO portal, which is regulated by the Ministry of Health and Family Welfare. The application is filed in Form MD-14 and must be submitted to the Central Licensing Authority along with the required supporting documents. While applying, it is important to correctly classify the medical device and clearly mention details of any accessories that will be used with it. You must also provide a valid MD-42 license of the authorized Indian agent, along with a properly drafted cover letter and other necessary documents as per the Medical Devices Rules. Ensuring complete and accurate documentation helps avoid delays in the approval process.

In India, manufacturers of primary packaging materials generally do not require a CDSCO manufacturing license unless the material itself is classified as a medical device or accessory under the Medical Devices Rules, 2017; however, they must comply with applicable quality and safety requirements expected by medical device or pharmaceutical manufacturers. For regulated and export markets, compliance with standards such as ISO 15378 for GMP-based quality systems and preparation of a US FDA Type III DMF is commonly required, along with supporting documentation on material safety, traceability, and consistency. Operon Strategist supports manufacturers through ISO 15378 implementation, Type III DMF preparation, quality system development, gap assessments, and audit readiness to ensure alignment with global regulatory expectations.

As per the Medical Devices Rules, 2017 (IMDR 2017), a medical device means any instrument, apparatus, appliance, implant, material, or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic or therapeutic purposes. It is intended for use in human beings or animals for diagnosis, prevention, monitoring, treatment, or alleviation of disease or injury; investigation, replacement, or modification of anatomy or a physiological process; supporting or sustaining life; disinfection of medical devices; or control of conception. A medical device does not achieve its primary intended action by pharmacological, immunological, or metabolic means, although it may be assisted in its function by such means.

Primary packaging materials for medical devices are the packaging components that come into direct contact with the device and form part of the sterile barrier system (where applicable), ensuring the device is protected from contamination, physical damage, and environmental factors throughout manufacturing, sterilization, storage, transportation, and use. These materials play a critical role in maintaining sterility, integrity, traceability, and usability of the device until the point of use, and therefore must be designed and validated in accordance with applicable standards such as ISO 11607 (Packaging for Terminally Sterilized Medical Devices), ISO 13485 quality system requirements, and relevant biocompatibility and material safety considerations. Properly designed primary packaging ensures product safety, shelf-life stability, and regulatory compliance in global markets. Operon Strategist provides end-to-end consulting support including material selection guidance, packaging validation strategy, facility and process alignment, DMF support (where required), and implementation of ISO-compliant quality systems for primary packaging manufacturers and medical device companies. 

IEC (Import Export Code)

It is the first requirement you before you start an import/export in India. An IEC is important for the import and export of goods. The IEC is issued by the Directorate General of Foreign Trade (DGFT) Ministries of Commerce and Government of India.

Medical Device Import License.

Importer of Medical Device has to adhere to various rules set by the national regulatory bodies of India. The main regulatory body of India is Central Drugs Standard Control Organization (CDSCO). A License is issued by CDSCO after examining various documents of Manufacturer of Medical Devices outside India and importer from India 

After analysing of the documents with the applications under the rule:

[1] rule of 34 on the basis of inspection report if the inspection has been carried out the central licensing authority may, on be satisfied and grant license in Form MD-15 or may reject such application for which reasons shall be recorded in writing, within a period of 9 months from the date of application.

[2] if the license gets rejected, the applicant can appeal to the central government within the period of forty to fifty days and that government may after such enquiries into the matter are considered necessary pass orders in relation there to within the period of ninety days from the date of appeal

[3] where a free sale certificate has already been issued in respect of any medical device by the national regulatory authority or other competing authority of any of the countries namely Australia, Canada, Japan, European Union Countries, or the United States of America, a license shall be granted under sub rule [1] to the applicant without carrying out any investigation.

[4] where a medical device is imported from countries other than those referred to in sub-rule [3] the license in case of class c and class d medical devices may be granted after its safety and effectiveness has been established through clinical investigation in India.

In order to market medical devices in the European Union, the CE certification is needed . This certification states that the devices meets to all the regulatory requirements of the Medical Devices Directive [MDD].

The process for the approval of Medical Device in Europe is:

Classification of the Medical Devices based on the MDD guidelines.

  • For all Classes Is II and III except class I non (non sterile, non measuring) implement Quality Management System (QMS) accordance to Annex II or V of the MDD

Most of the companies apply for the ISO 13458 standard to achieve the QMS compliance.

  • For class I non (non sterile, non measuring) QMS is not formally required. However a PMS procedure is required, though not audited by Notified Bodies.

 Medical Device Directives(MDD) are the guidelines for CE Marking which after 2020 will be replaced with Medical Device Regulation.(MDR).

Medical Devices are generally based on Risk. The actual risk classification of each medical device depends on its intended use and purpose.

Classification of medical devices under the new rule of “Medical Devices Rules 2017” are classified as:

  • Low Risk – Class A – (Surgical Retractors, Tongue Depressors)
  • Low Moderate Risk – Class B – (Hypodermic Needles, Suction equipment)
  • Moderate High Risk ­– Class C – ( Lung Ventilator, Bone Fixation Plate)
  • High Risk – Class D – (Heart Valves, Implantable Defibrillator)

A 510K is a Premarket Submission made to FDA to state that the medical device which is to be marketed is at least as safe and effectual that is considerably equal to a legally marketed device that is not subject to PMA. A PMA is a premarket approval it is the process of scientific and regulatory review analyse the safety and effectiveness of Class III medical device the applicant must receive the FDA approval of its PMA application prior to the marketing the device. Companies doing 510k submissions have to compare their devices to one or more legally marketed devices and make and support their substantial equivalence claims. A lawfully marketed device is a device that has been legally marketed or a device that has been reclassified from Class III to Class II or Class I SE through the 510k process, or else a device that was granted marketing authorization.

Drug Master File (DMF) is a document prepared by a pharmaceutical manufacturer and submitted solely at its caution to the appropriate regulatory authority in the conscious drug market. A DMF is a submission to the food and drug administration (FDA) that may be used to provide confidential information about facilities. There is no regulatory requirement to file a DMF. But the document provides the regulatory authority with confidential and detailed information about facilities, processes, or articles used in the manufacturing packaging, processing, storing of one or more human drugs. Basically a drug master file is filed when two or more firms work in partnership on developing or manufacturing a drug product or a pharmaceutical industry. The DMF filing allows a firm to protect its conceptual property from its partner while observing with regulatory requirements for disclosure of processing details.

A technical file includes drawings, reports, review reports, specifications, meeting minutes, labels, instructions for use, software source code etc. Annex II of EU medical device regulation contains an overview of the contents and structure of a technical file. Technical file is a set of documents that describes a product and can prove that the product was designed according to the requirements of the Quality Management System. A CE marking technical file or design dossier Class III is a comprehensive description of your device intended to demonstrate compliance with European requirements. All products that have CE marking process must have a technical file which must contain the information the proves that the product conforms with the EU directives with the CE marked products. EU enforcement authorities may demand a copy of the technical file for many years after the last product was made. Medical Device Regulation (MDR) manufacturers need to maintain a MDR technical documentation as an evidence of conformity with the relevant legislation. Customers usually do not have the access to the technical file. A technical file is usually based on a document archive system that ensures longevity of documents and can either be on paper or in a electronic files.

Design Control labels the implementation of a formalistic technique to the ways of product development activities. It is often necessary by regulation for the appliance of such practice when designing and developing products within regulated industries e.g. medical devices. The Food and Drug Administration FDA has stated that medical device manufacturers that want to marketise certain classifications of medical devices in the USA follow design control requirements (21 CFR 820.30). Few firms regard Risk Management and Design Control as they are linked together but they follow separate procedures, not actualizing that the relation between the user needs, design inputs, dangers and dangerous circumstances. Design control conditions that when the suppliers or manufacturers get a product to design controls they may discover and maintain the correct documentation to assure the specified design requirements are.

A clean room is a controlled environment used in industries such as medical devices, pharmaceuticals, biotechnology, and other contamination-sensitive manufacturing sectors, where the concentration of airborne particles, microorganisms, and other contaminants is maintained within specified limits to prevent product contamination and ensure safety and quality. Clean rooms are engineered with controlled airflow systems utilizing HEPA or ULPA filtration, regulated temperature and humidity, defined pressure differentials, and validated air change rates to achieve the required cleanliness classification. Personnel must follow strict gowning and entry procedures through airlocks or gowning areas to minimize particulate and microbial introduction. Clean rooms are classified in accordance with ISO 14644 based on allowable particle counts, and their design, qualification, and monitoring are aligned with ISO 13485 and applicable regulatory requirements. These environments are essential for the manufacture of sterile and high-risk products, ensuring regulatory compliance, sterility assurance, and protection of product integrity throughout production.

ISO 13485 is the worldwide acknowledged standard by the International Standards Organization for medical device Quality Management System. The standard states the things required for QMS that helps companies execute and exhibit the abilities to provide high-quality medical devices that reach up to customers and regulatory requirements. ISO 13485 can be used by any company involved in the transfer of medical devices, providing, support phases.) Furthermore, it can also be used by external or internal auditors to support the inclusive audit process. No, it is not a mandatory requirement for CDSCO manufacturing license.

ISO 13485 is the worldwide acknowledged standard by the International Standards Organization for medical device Quality Management System. The standard states the things required for QMS that helps companies execute and exhibit the abilities to provide high-quality medical devices that reach up to customers and regulatory requirements. ISO 13485 can be used by any company involved in the transfer of medical devices, providing, support phases.) Furthermore, it can also be used by external or internal auditors to support the inclusive audit process. No, it is not a mandatory requirement for CDSCO manufacturing license.

A clean room is required in medical device manufacturing to control environmental contamination and ensure that products meet defined safety, quality, and regulatory requirements, particularly for sterile or high-risk devices. It maintains extremely low levels of airborne particles, microorganisms, and other contaminants through the use of HEPA/ULPA filtration, controlled airflow patterns, pressure differentials, and monitored temperature and humidity. These controls prevent product contamination during critical manufacturing, assembly, and packaging operations, thereby ensuring product integrity, sterility assurance, and consistent performance. Clean rooms are designed, classified, and monitored in accordance with ISO 14644 standards, while their operation is integrated into the ISO 13485 quality management system and applicable regulatory expectations. Implementing a properly qualified clean room is essential for regulatory compliance, risk control, and validation of manufacturing processes for medical devices. 

quipment qualification and installation management ensure that manufacturing equipment is correctly installed, tested, and ready for compliant production. This includes Factory Acceptance Testing (FAT) to verify performance before delivery, Site Acceptance Testing (SAT) to confirm proper installation and integration at the facility, calibration of critical instruments, and documentation review for regulatory compliance. Installation Qualification (IQ) and Operational Qualification (OQ) are then performed to demonstrate that the equipment operates reliably within defined parameters, supporting GMP-compliant and efficient manufacturing operations.

Material and personnel flows are optimized in the layout through careful planning and workflow mapping to minimize crossovers, reduce contamination risks, and enhance operational efficiency. This involves defining dedicated entry and exit routes for personnel and materials, integrating pass-through systems and airlocks to control movement between classified areas, and arranging workstations in a logical sequence that supports unidirectional process flow. Such structured design prevents mix-ups, reduces unnecessary handling, and improves overall productivity while maintaining GMP compliance and effective contamination control. Operon specializes in developing these optimized, GMP-aligned layouts tailored to specific manufacturing and regulatory requirements.

A Product Financial Feasibility Study for medical devices is a comprehensive techno-commercial evaluation conducted to determine whether a proposed device can be successfully developed, manufactured, and commercialized in a compliant and financially sustainable manner. The study integrates technical assessment of product design, materials, manufacturing processes, and required infrastructure with regulatory pathway analysis based on device classification and target markets (such as US FDA, CE Marking, or CDSCO). It further examines capital investment requirements for facility setup, cleanroom environments, machinery, validation, and quality systems aligned with standards like ISO 13485. Operational costs—including manpower, raw materials, supply chain logistics, and ongoing compliance—are analyzed alongside market demand, competitive positioning, pricing strategy, and reimbursement considerations. Financial modeling is then performed to project revenue, margins, break-even timelines, and return on investment (ROI), enabling stakeholders to make data-driven decisions on project viability, scalability, and risk mitigation before proceeding to implementation.

Clean rooms are classified depending upon the cleanliness of the air in the rooms. Clean room classes are the amount of cleanliness the room follows with, as per the size and amount of particles per volume of the air. Clean rooms are laboratory facilities used for industrial production used for manufacturing of the medical or pharmaceutical items.

Classes required for Clean room

ISO – 5 – 100

ISO – 6 – 1000

ISO – 7 – 10000

ISO – 8 – 100000

ISO – 9 – 1000000

WHO: The World Health Association is a particular organization of the assembled countries that are concerned about international public health. The WHO is a member of the united nations development group. Its antecedent, the health Association was an agency of the league of nations.

cGMP:  cGMP states to the Current Good Manufacturing Practices guidelines authorized by FDA regulations. cGMP accommodates frameworks that guarantee proper design monitoring, checking, control of manufacturing procedures and facilities. Adherence to the cGMP guidelines that guarantee identity, quality, strength, and control. GMP certification is the term perceived worldwide for the control and the management of manufacturing, testing and general quality control of food and pharmaceutical products.

Before the introduction of a new medical device in the Indian market, the manufacturer has to accept certain regulations. If a sole person wants to import a new medical device, a license for the manufacturer of the product is necessary. The Central Drugs Standard Control Organization known as the (CDSCO) is a regulatory body, for the Indian medical devices industry, under regulatory provisions of the Drugs & Cosmetics Act 1940 & 1945. CDSCO is the national regulatory body for Indian medical device industries and pharmaceutical industries. It is the licensing authority which approves any new medical device import to India. The Indian CDSCO is controlled and governed by Directorate General of Health Services which comes under the ministry of health and family wealth government of India. The CDSCO regulations are responsible for the registration and sale of notified medical devices in India.

ISO: ISO 13485 is the worldwide acknowledged standard by the International Standards Organization for medical device Quality Management System. The standard states the things required for QMS that helps companies execute and exhibit the abilities to provide high-quality medical devices that reach up to customers and regulatory requirements. ISO 13485 can be used by any company involved in the transfer of medical devices, providing, support phases. Furthermore, it can also be used by external or internal auditors to support the inclusive audit process.

21 CFR Part 820: FDA 21 CFR Part 820: covers up the process used in & the facilities and controls used for the design, manufacture, packaging, labelling, storage, installation, & servicing of medical devices. Manufacturers are inspected by the US FDA as per Part 820 & only compliance with the requirements is assessed. FDA 21 CFR known as the Quality System Regulation QSR acknowledges Current Good Manufacturing Practices CGMP regulations that govern the methods used in and the services, and controls used for, the design, manufacturing, packaging, labelling, storage, installation and servicing for all finished devices willful for human use. These requirements are necessary to ensure that medical devices are safe and effective for use. Medical device manufacturers undergo FDA inspections to assure FDA 21 CFR 820 agreement.

To launch a medical device, the manufacturer has to adhere to numerous norms set by way of the countrywide regulatory bodies of India. The number one regulatory frame for medical devices in India is the central drugs trendy control organization (CDSCO). The applications for all elegance of scientific gadgets are made to the important licensing Authority (CLA) in which the Drug Controller General of India (DCGI) takes obligation for the approval of manufacturing, registration, import, and sale of medical devices in India. The medical devices might also or won’t want to be registered before the sale. While there may be no want for registration, the producer must gain a no-objection certificate (NOC) from the DCGI before releasing the product inside the marketplace. Whilst the medical device to be launched is imported, it has a fixed of issued steps to be observed like filling of a registration form at the side of the fees. The form will include the applicant’s and manufacturer’s details, product facts, the regulatory fame of the product, info of good manufacturing practices included, and publish-marketing surveillance at the side of an assignment shape. The retailers, stockiest, and importers shall also gain the respective sale licenses from the nation Licensing government (SLA). The nation Licensing Authority is responsible for the control and enforcement of regulations related to the sale, stock, providing on the market of medical devices in India.

Medical Device Manufacturing in India:

There is the national regulatory body like CDSCO for Indian medical devices and pharmaceuticals, it is the licensing authority. The role of CDSCO is to provide the approval to any new medical device which is in the process to be imported to India. Within CDSCO, Drug Controller General of India (DCGI) is the final authority and controls medical devices and pharmaceuticals. Drug Controller General of India is in charge of endorsement of licenses of particular categories of Drugs such as IV-Fluids, blood and blood products, Vaccines and all medical devices. The Medical device manufacturing process is classified and categorized under the CDSCO guideline. “Those medical devices fall under Class A – Class B – Class C – and Class D according to their risk factors.


Medical Devices Manufacturing in the US

Under the Food, Drug, and Cosmetic Act, the U.S. Food and Drug Administration recognizes three classes of medical devices, based on the level of control necessary to assure safety and effectiveness. The medical devices fall under Class I, Class II & Class III.

MDSAP gives access for a manufacturer to register medical devices in five countries with one quality management system as implemented as per MDSAP. Five countries USA, Japan, Brazil, Canada and Japan. The Medical Device Single Audit Program – or MDSAP – permits a single regulatory audit of a medical device producer’s quality management system to fulfill the requirements of various regulatory authorities (RAs). MDSAP was created by the International Medical Device Regulators Forum (IMDRF) to address the fast development that has brought about increasingly advanced devices that require more prominent controller ability to screen. MDSAP likewise addresses the detonating worldwide exchange the medical device part. Its objective for building up a solitary review model was to advance more prominent arrangement and adaptable utilization of administrative assets through work-sharing and common acknowledgement among controllers while regarding the sway of every power.

No. MDSAP is acceptable in five countries, USA, Japan, Brazil, Canada and Japan. Rest of the countries have separate QMS requirements like ISO 13485 for EU countries.

The Therapeutic Goods Administration (TGA), a unit of the Australian government’s Department of health and ageing, supervises medical device regulation in Australia. Enrolling your device with the TGA involves risk based characterization; consistence with quality safety execution and standards consistence with regulatory control for manufacturing forms; posting in the Australian Register of Therapeutic Goods; and post-showcase cautiousness programs. Gadgets that have just earned CE certification from European Notified Bodies can all the more effectively validate adjustment to TGA requirements. Producers should likewise give Declarations of Conformity to the Australian Regulations so as to enroll with the TGA.

The Medical Device Single Audit Program (MDSAP) is a global initiative intended to accelerate medical device regulation harmonization by allowing a single regulatory audit to satisfy the requirements of multiple jurisdictions around the world

There are 3 steps to prepare for the MDSAP:

1) Conduct a Gap Assessment of all Standard Operating Procedures (SOP’s) and processes

Every manufacturer struggles to understand and adapt their processes when design control requirements were formally introduced during the switch from GMP’s to QSR’s, the MDSAP presents a similar learning curve with the introduction of risk requirements.

The MDSAP follows in line with a greater movement toward a more risk-based approach around the world. This program expands the definition of “risk” beyond risk assessments for products alone to encompass the entire quality system.

2) Develop and Implement a Comprehensive Risk Assessment Program

Regulators now expect manufacturers to conduct risk assessments on processes throughout the quality system. In particular, your Notified Body will be looking for a robust risk assessment program in order to gauge and measure your investment in assessing risk beyond product quality and safety alone.

In many cases, developing such a program will require companies either augment their current Quality staff or use a third-party consultant. In this case, an experienced consultant can bring firsthand knowledge gained through working with other manufacturers to build a program proven to be effective and aligned with regulatory expectations.

It’s important to note that the concept of risk still remains a tripping point for many regulated manufacturers. Given its recently-expanded scope, even veteran Quality professionals at the helm of smaller risk assessment programs struggle to know where to start when widening these efforts to the entire quality system.

Experienced third party experts are especially valuable not only for developing effective programs but prioritizing their implementation and ensuring sufficient documentation while training staff to successfully use the expanded program.

3) Ensure employees aren’t just trained in ISO 13485:2016, but fully “competent” in it

In addition to conducting a thorough gap assessment and developing a comprehensive risk assessment program, device companies that haven’t yet trained their employees to the ISO 13485:2016 standard should ensure they do so in preparation for the MDSAP.

This updated standard aligns incredibly closely to FDA’s regulations and an effective training program will prepare staff for the expectations that are quickly approaching.

Companies with robust FDA quality systems shouldn’t find the new ISO standard a considerable challenge beyond the new areas of risk-related requirements. Many industry experts predict the next version of FDA’s QSR will make risk its primary focus, in keeping with the broader trend seen throughout the world. As such, device manufacturers should make risk their primary focus as well.

Perhaps even more importantly, device companies must expand their concept of training beyond what was accepted in the past. One term in particular sets the bar for training much higher in the updated standard: competence.

Setting up a medical device manufacturing facility involves defining product and capacity requirements, conducting feasibility assessment, and developing a detailed User Requirement Specification (URS). This is followed by designing a GMP-compliant facility layout with proper zoning, personnel and material flow planning, and defined room specifications for cleanroom installation. The project also includes selection of suitable, standards-compliant machinery, planning of utilities and infrastructure such as HVAC and controlled environments, and coordination of equipment installation. Subsequently, qualification activities (IQ/OQ/PQ), process validation, and operational readiness are completed to enable a smooth transition to commercial production.

A GMP-compliant facility layout is designed by first understanding the product type, manufacturing process, and risk classification, and then translating these requirements into a structured layout that ensures contamination control, traceability, and operational efficiency. The design establishes unidirectional flow of materials and personnel to avoid cross-contamination and mix-ups, with clearly defined zones such as raw material areas, controlled manufacturing spaces, cleanrooms, inspection, and finished goods storage. Cleanroom areas are planned with appropriate classifications, airlocks, and pressure differentials, while support areas such as gowning, utilities, and waste movement are segregated. The layout also incorporates logical equipment placement, adequate space for validation and maintenance, and compliance with ISO 13485 and GMP requirements to ensure smooth workflow, regulatory readiness, and consistent product quality.

Selecting the right manufacturing machinery and automation for medical device production requires careful evaluation of process requirements, product specifications, and targeted production capacity to ensure precision, repeatability, and consistent quality. It is essential to identify qualified suppliers with proven experience in the medical device sector, strong technical capabilities, and reliable after-sales service support. A detailed technical assessment of the equipment—including design suitability, compliance with applicable standards, validation readiness, and integration with quality and traceability systems—must be performed before procurement. Additional considerations such as scalability for future expansion, ease of maintenance, availability of spare parts, and documentation support are critical to achieving regulatory compliance, operational efficiency, and long-term manufacturing reliability.

Equipment (machinery) qualification and process validation play a critical role in project execution by ensuring that the manufacturing system is capable of consistently producing products that meet predefined specifications and regulatory requirements. Equipment qualification verifies that machines are properly installed, operate as intended, and perform reliably through Installation Qualification (IQ) and Operational Qualification (OQ). Once the equipment is qualified, process validation—demonstrated through Performance Qualification (PQ)—confirms that, under defined operating conditions, the entire process can repeatedly deliver conforming product during routine production. Together, these activities establish process reliability, minimize operational risks, and support compliance with applicable standards such as ISO 13485 and global regulatory expectations, forming a key milestone for commercial readiness.

Cleanroom qualification includes a series of performance tests to verify that the controlled environment meets the required ISO 14644 and GMP standards. These tests typically include Airflow Volume Testing to confirm adequate air changes per hour (ACR), Differential Pressure Testing to ensure proper pressure cascades between areas, HEPA Filter Leakage Testing to validate filtration integrity, Temperature and Relative Humidity Testing to maintain specified environmental conditions, and Particle Count Testing to confirm the achieved cleanliness class. Additional evaluations such as Recovery Testing assess how quickly the cleanroom returns to specified conditions after contamination, while Lighting Level Testing ensures adequate illumination for safe and compliant operations. Together, these tests demonstrate that the cleanroom can consistently support controlled manufacturing activities.

Facilities are designed using modular concepts, allowing additional equipment, extended cleanroom areas, and increased utilities without disrupting existing validated operations.

From a medical device manufacturing perspective, the feasibility study evaluates the total investment and operating costs required to establish and maintain a compliant production environment. This includes capital expenditure (CAPEX) for facility setup such as cleanroom infrastructure, utilities, and environmental control systems; procurement and installation of manufacturing machinery, tooling, and inspection equipment; and implementation of quality management systems in line with ISO 13485 and GMP requirements. It also assesses operational expenditure (OPEX), including skilled manpower, raw materials, consumables, maintenance, calibration, and supply chain management. Regulatory and validation costs—such as product testing, documentation, certification, and execution of qualification and validation activities—are factored in to ensure compliance. These elements are then analyzed through financial modeling to estimate production costs, pricing strategy, revenue potential, break-even timelines, and overall return on investment, enabling informed and risk-mitigated business decisions.

Operon Strategist supports clients through a structured, end-to-end approach to feasibility and market assessment by combining technical, regulatory, and commercial expertise. This includes conducting detailed techno-commercial evaluations covering product requirements, manufacturing processes, facility and machinery planning, and capital investment analysis aligned with GMP and ISO 13485 expectations. Operon also assesses applicable regulatory pathways and compliance requirements to ensure realistic timelines and cost planning for approvals. In parallel, market analysis is performed to evaluate demand, competitive landscape, pricing benchmarks, and commercialization strategies. By integrating engineering, regulatory, and market intelligence, Operon enables clients to make well-informed investment decisions, minimize project risks, and establish a clear roadmap for successful implementation and market entry.

Market analysis is essential before introducing a new medical device because it provides data-driven insights into clinical demand, target patient populations, and healthcare infrastructure that will influence product adoption. It involves evaluating epidemiological data, current treatment practices, and unmet clinical needs to validate the device’s relevance in the intended market. The analysis also includes detailed competitor benchmarking to understand existing technologies, regulatory approvals, pricing structures, and differentiation opportunities. In addition, it assesses reimbursement frameworks, procurement models (public vs. private healthcare), and distribution channels, all of which directly impact commercialization strategy and revenue potential. By aligning technical capabilities with real market requirements, manufacturers can define optimal pricing, forecast sales volumes, plan production capacity, and mitigate regulatory and commercial risks, ensuring a structured and successful market entry.

Operon Strategist provides comprehensive Product and Process Engineering support to help clients establish and operationalize medical device manufacturing facilities. This includes identifying and evaluating suitable machinery suppliers, raw material vendors, and other critical equipment required for production based on the product and regulatory requirements. Operon assists in machinery selection by reviewing technical specifications, process compatibility, and compliance considerations, and facilitates connections between clients and qualified suppliers. In addition, Operon helps identify cleanroom vendors, utility providers, and other partners necessary for facility setup, including inputs for detailed engineering and layout planning. This integrated approach ensures that clients have access to the right technologies, vendors, and technical guidance needed to establish a compliant and efficient manufacturing operation.